A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy

Kathryn M Meurs1, Michelle M Norgard, Martina M Ederer

  • 1Department of Veterinary Clinical Sciences, Washington State University College of Veterinary Medicine, Pullman, WA 99164, USA. Meurs@vetmed.wsu.edu

Genomics
|May 25, 2007
PubMed

Insights

Two distinct MYBPC3 gene mutations cause hypertrophic cardiomyopathy (HCM) in unrelated cat breeds. This research identifies a new mutation in Ragdoll cats, highlighting independent genetic events in feline HCM.

Area of Science:

  • Genetics
  • Cardiology
  • Veterinary Medicine

Background:

  • Familial hypertrophic cardiomyopathy (HCM) is a common inherited heart disease.
  • Mutations in sarcomeric genes, such as MYBPC3, are known causes of HCM.
  • Feline HCM serves as a relevant large-animal model for studying human disease.

Purpose of the Study:

  • To identify the genetic cause of HCM in Ragdoll cats.
  • To investigate the specific MYBPC3 gene mutation in this breed.
  • To compare this mutation with previously identified feline MYBPC3 mutations.

Main Methods:

  • Genetic sequencing of the MYBPC3 gene in affected Ragdoll cats.
  • Analysis of mutation effects on protein structure and function.
  • Comparison of mutation location and breed lineage with previously identified feline HCM mutations.

Main Results:

  • A novel mutation in the MYBPC3 gene was identified in Ragdoll cats with HCM.
  • This mutation involves a change from arginine to tryptophan, altering protein structure.
  • The mutation is distinct from the one found in Maine Coon cats, indicating independent origins.

Conclusions:

  • Two separate, de novo MYBPC3 mutations cause HCM in unrelated feline breeds.
  • This underscores the genetic heterogeneity of feline HCM.
  • The MYBPC3 gene is a significant locus for inherited cardiomyopathies in both humans and cats.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...